Edit

3 Days, 3 Ways Lombardo's Vetoes Cost Nevadans: Prescription Drugs

Government and Politics

January 14, 2025


Last legislative session, as health care costs continue to rise, Joe Lombardo vetoed a bill that would have lowered the price of prescription drugs to the Medicare-negotiated rate for all Nevadans, not just those on Medicare. A report found that after vetoing AB250, Joe Lombardo received nearly $100,000 in campaign cash from big drug companies. Prior to his veto, which cited “many arguments made by the [pharmaceutical] industry,” Lombardo had only received $11,000 from pharma interests. When given the opportunity to choose Nevadans over special interest donors, Lombardo put political self-interest over helping Nevadans. 

Nevada State Democratic Party spokesperson Tai Sims: 

“Democrats prioritized taking on the issues affecting everyday Nevadans when they passed legislation to lower prescription drug prices. The truth is that with a stroke of a pen Joe Lombardo could have lowered the price of prescription drugs for all Nevadans, but instead he vetoed groundbreaking legislation and sold out Nevada families all for his own selfish political gain. While health care costs continue to rise and Nevadans struggle to pay for lifesaving prescription drugs, Lombardo deposited checks from his true beneficiaries: big drug companies.”

If you missed earlier editions, you can find them here:

Monday: Education